Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Sakai Kimberly

14 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Safety 11 Depression 9 Clinical Trial 6 Cancer Patients 3 Anxiety 3 Adverse Events 3 Drug Interactions 3 Observational Study 3 PTSD 2 Biomarkers 1 Mitochondrial Function 1 Inflammation 1

Journals

The Journal of Clinical Psychiatry 1 Biological Psychiatry 1 Psychedelic Medicine 1 Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 1 The American journal of psychiatry 1 General hospital psychiatry 1 Psychopharmacology 1 JAMA psychiatry 1

Publication history

Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal IdeationThe Journal of Clinical Psychiatry · 2026-05-13 356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s DiseaseBiological Psychiatry · 2026-05-01 “To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group TherapyPsychedelic Medicine · 2025-08-25 Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-07-01 Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial.The American journal of psychiatry · 2025-01-01 Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression.General hospital psychiatry · 2025-01-01 Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms.Psychopharmacology · 2024-08-01 Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.JAMA psychiatry · 2024-06-01 Inhibition of cytochrome P450 3A4 enzyme activity by alkaloid psilocin from magic mushrooms: potential for drug interactionsDrug Metabolism and Pharmacokinetics · 2024-04-01 Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder.Cancer · 2024-04-01 Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption.Journal of psychopharmacology (Oxford, England) · 2023-01-01 Group psychedelic therapy: empirical estimates of cost-savings and improved access.Frontiers in psychiatry · 2023-01-01 Exploring the Use of Psilocybin Therapy for Existential Distress: A Qualitative Study of Palliative Care Provider Perceptions.Journal of psychoactive drugs · 2022-01-01 "A sense of the bigger picture:" A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use.PloS one · 2022-01-01

Author directory